Maynard Um
-
-
-
-
-
-
-
Larimar Therapeutics (LRMR) PT Raised to $12 at Wedbush
-
-
-
-
-
-
-
Citizens Reiterates Market Outperform Rating on Larimar Therapeutics (LRMR)
-
-
-
-
-
-
-
Larimar Therapeutics (LRMR) PT Lowered to $18 at Citizens JMP
-
-
-
-
-
-
-
Larimar Therapeutics publishes nonclinical data on nomlabofusp
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Larimar Therapeutics (LRMR)
-
-
-
-
-
-
-
Leerink Partners Reiterates Outperform Rating on Larimar Therapeutics (LRMR)
-
-
-
-
-
-
-
Citi Reiterates Buy Rating on Larimar Therapeutics (LRMR), Opens 90-Day Upside Catalyst Watch
-
401,644 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

